Patent Assignment
Reel/Frame 013323/0586
Security Interest
Recorded: 2002-09-25
Received: 2002-10-01
Pages: 30
Assignor
ISTA PHARMACEUTIALS, INC.
Executed: 2002-09-19
Assignees
SPROUT CAPITAL IX, L.P.
11 MADISON AVENUE, 13TH FL., C/O SPROUT GROUP, NEW YORK, NY, 10010, UNITED STATES
SPROUT ENTREPRENEURS' FUND, L.P.
11 MADISON AVENUE, 13TH FLOOR, C/O SPROUT GROUP, NEW YORK, NY, 10010, UNITED STATES
DONALDSON, LUFKIN & JENRETTE SECURITIES CORPORATION, AAS NOMINEE FOR: DLJ FIRST ESC, L.P., EMA 2001 PLAN, L.P., CSFB 2001 INVESTORS, L.P. CREDIT SUISSE FIRST BOSTON RPIVATE EQUITY, INC., DOCKLANDS 2001 PLAN, L.P., PARADEPLATZ 2001 PLAN, L.P.
11 MADISON AVENUE, 13TH FLOOR, C/O SPROUT GROUP, NEW YORK, NY, 10010, UNITED STATES
INVESTOR GROWTH CAPITAL LIMITED NATIONAL WESTMINSTER HOUSE
LE TRUCHOT, ST. PETER PORT, GUERNSEY GY1 4PM, GB1, UNITED KINGDOM
INVESTOR GROUP L.P. NATIONAL WESTMINSTER HOUSE
LE TRUCHOT, ST. PETER PORT, GUERNSEY GY1 4PW, GB1, UNITED KINGDOM
DIONIS TRUST
14 NASSAU STREET, C/O GUND INVESTMENT CORPORATION, PRINCETON, NJ, 08542, UNITED STATES
GRANT GUND 1978 TRUST
14 NASSAU STREET, C/O GUND INVESTMENT CORPORATION, PRINCETON, NJ, 08542, UNITED STATES
G. ZACHARY GUND 1978 TURST
14 NASSAU STREET, C/O GUND INVESTMENT CORPORATION, PRINCETON, NJ, 08542, UNITED STATES
KBL, HEALTHCARE, LP
645 MADISON AVENUE, NEW YORK, NY, 10022, UNITED STATES
KBL PARTNERSHIP, LP
645 MADISON AVENUE, NEW YORK, NY, 10022, UNITED STATES
SANDERLING VENTURE PARTNERS V CO.-INVESTMENT FUND, L.P.
400 S. EL CAMINO REAL, SUITE 1200, SAN MATEO, CA, 94402, UNITED STATES
SANDERLING V BIOMEDICAL CO-INVESTMENT FUND, L.P.
400 S. EL CAMINO REAL, SUITE 1200, SAN MATEO, CA, 94402, UNITED STATES
SANDERLING V. LIMITED PARTNERSHIP
400 S. EL CAMINO REAL, SUITE 1200, SAN MATEO, CA, 94402, UNITED STATES
SANDERLING V BETEILIGUNGS GMBH & CO. KG
400 S. EL CAMINO REAL, SUITE 1200, SAN MATEO, CA, 94402, UNITED STATES
Covered Properties
(3)
Compositions and Methods for the Induction of Retinal Detachments
Application:
10/160,135 →
Method of Stabilizing Hyaluronidase with Annexin Ii
Application:
10/139,139 →
Biochemical Methods That Eliminate Corneal Scars, Opacification and Haze
Application:
09/975,039 →